Roche's response to COVID-19
Since the worldwide recognition of the novel coronavirus pandemic risk in January, we have been focused on the public health lab response to the outbreak of COVID-19. Despite the presence of industry supply challenges, Roche continues to demonstrate our commitment to providing testing platforms and required supplies to sustain and grow the testing capabilities of your lab.
Sample Extraction and Sequencing
Solutions for RNA extraction, sequencing and LDTs
RT-PCR Tests
High throughput, moderate complexity testing on the cobas 6800 platform for COVID-19 and infectious diseases
Immunochemistry Tests
COVID-19 serology, HIV, Hepatitis, Syphilis, and ToRCH testing all on one immunoassay platform
Point of Care & Population Health
Decentralized testing and results management platforms
